ETNB - 89bio stock dips on upsized pricing of $150.0 million securities offering
2023-12-07 07:54:08 ET
More on 89bio
- 89bio: Despite Peer Trial Setback, Potential Remains In NASH
- 89bio's Low Price Presents An Opportunity
- 89bio: Risk And Reward Balance In NASH Therapeutics
- 89bio announces proposed underwritten public offering of common stock and pre-funded warrants
- 89bio aligns with regulators on Phase 3 trials for NASH candidate
For further details see:
89bio stock dips on upsized pricing of $150.0 million securities offering